Cadrenal Therapeutics Inc (CVKD) Annual Balance Sheets

Annual · GAAP · USD millions
Access CVKD quarterly Balance Sheets →
From Cadrenal Therapeutics Inc through , shifts in Mar 31 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
Annual Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Mar 31 2025) (Dec 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent2.31
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments2.00
Interest Receivable, Current0.01
Deferred Costs, Current AS0.11
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.43
Total Current Assets2.86
Equipment/Property/Plant Net0.00
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Total Assets2.86
Liabilities
Accounts Payable, Current AC0.82
Accrued Liabilities, Current AC0.24
Other Liabilities, Current0.00
Total Current Liabilities1.06
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Total Liabilities1.06
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock43.25
Retained Earnings / Accumulated Deficit-41.46
Other Equity0.00
Common Stockholder's Equity1.80
Total Stockholder's Equity1.80
Liabilities & Stockholder's Equity2.86
4 historic quarters locked

Sign in to unlock the full Cadrenal Therapeutics Inc balance sheet history.

About Cadrenal Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-036946

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License